Trial intelligence / Profile preview

Dabigatran versus warfarin in atrial fibrillation patients post catheter ablation

IRCT2012122311855N1Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Sep 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of dabigatran and warfarin in Atrial fibrillation (AFib) (2 arms), sponsored by Tehran University of Medical Sciences. Started Sep 2011; status: completed.

02

Drugs

dabigatranwarfarin
03

Conditions

Atrial fibrillation (AFib)

Beyond the preview

Go deeper on IRCT2012122311855N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2012122311855N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call